{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:49:59Z","timestamp":1789588199366,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00702-026-03230-z","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:25:11Z","timestamp":1784816711000},"page":"1953-1962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic schizophrenia versus Alzheimer\u2019s disease: neuroimaging perspectives on the late-life course of schizophrenia"],"prefix":"10.1007","volume":"133","author":[{"given":"Maryam","family":"Noroozian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Givian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouchehr Seyedi","family":"Vafaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"1","key":"3230_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41537-025-00680-4","volume":"11","author":"JS Park","year":"2025","unstructured":"Park JS, Kim S, Jeong D, Choi JP, Jeong H, Park AJ, Kim YS, Lee J, Kim SH (2025) Dementia in older adults with schizophrenia: a 12-year analysis of prevalence, incidence, and treatment patterns in south korea. Schizophrenia 11(1):134","journal-title":"Schizophrenia"},{"key":"3230_CR2","doi-asserted-by":"publisher","first-page":"1629032","DOI":"10.3389\/fpsyt.2025.1629032","volume":"16","author":"Z Zhan","year":"2025","unstructured":"Zhan Z, Wang J, Shen T (2025) Results of the global burden of disease study for schizophrenia: trends from 1990 to 2021 and projections to 2050. Front Psych 16:1629032","journal-title":"Front Psych"},{"issue":"6","key":"3230_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s004060070002","volume":"250","author":"A Jablensky","year":"2000","unstructured":"Jablensky A (2000) Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 250(6):274\u2013285","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"12","key":"3230_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamapsychiatry.2021.2584","volume":"78","author":"K Jonas","year":"2021","unstructured":"Jonas K, Abi-Dargham A, Kotov R (2021) Two hypotheses on the high incidence of dementia in psychotic disorders. JAMA Psychiat 78(12):1305\u20131306","journal-title":"JAMA Psychiat"},{"key":"3230_CR5","doi-asserted-by":"crossref","unstructured":"Cai L, Huang J (2018) Schizophrenia and risk of dementia: a meta-analysis study. Neuropsychiatric disease and treatment. pp 2047\u20132055","DOI":"10.2147\/NDT.S172933"},{"issue":"6","key":"3230_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jamapsychiatry.2021.0042","volume":"78","author":"TS Stroup","year":"2021","unstructured":"Stroup TS, Olfson M, Huang C, Wall MM, Goldberg T, Devanand DP, Gerhard T (2021) Age-specific prevalence and incidence of dementia diagnoses among older us adults with schizophrenia. JAMA Psychiat 78(6):632\u2013641","journal-title":"JAMA Psychiat"},{"issue":"1","key":"3230_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11920-024-01570-9","volume":"27","author":"L Grassi","year":"2025","unstructured":"Grassi L, McFarland D, Riba M, Ferrara M, Zaffarami G, Belvederi Murri M, Cruciata M, Caruso R (2025) The challenging problems of cancer and serious mental illness. Curr Psychiatry Rep 27(1):41\u201357","journal-title":"Curr Psychiatry Rep"},{"key":"3230_CR8","doi-asserted-by":"publisher","first-page":"1629032","DOI":"10.3389\/fpsyt.2025.1629032","volume":"16","author":"T Shen","year":"2025","unstructured":"Shen T, Zhan Z, JiaMing W (2025) Results of the global burden of schizophrenia study: 1 trends from 1990 to 2021 and projections to 2050. Front Psych 16:1629032","journal-title":"Front Psych"},{"key":"3230_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S2045796019000891","volume":"29","author":"H He","year":"2020","unstructured":"He H, Liu Q, Li N, Guo L, Gao F, Bai L, Gao F, Lyu J (2020) Trends in the incidence and dalys of schizophrenia at the global, regional and national levels: results from the global burden of disease study 2017. Epidemiology and psychiatric sciences 29:91","journal-title":"Epidemiology and psychiatric sciences"},{"issue":"1","key":"3230_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101078","volume":"37","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Fang Y, Zheng J, Guan S, Wang M, Hong W (2024) The burden of depression, anxiety and schizophrenia among the older population in ageing and aged countries: an analysis of the global burden of disease study 2019. General Psychiatry 37(1):101078","journal-title":"General Psychiatry"},{"issue":"2","key":"3230_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GMD Collaborators","year":"2022","unstructured":"Collaborators GMD et al (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. The Lancet Psychiatry 9(2):137\u2013150","journal-title":"The Lancet Psychiatry"},{"key":"3230_CR12","doi-asserted-by":"crossref","unstructured":"Peritogiannis V, Ninou A, Samakouri M (2022) Mortality in schizophrenia-spectrum disorders: recent advances in understanding and management. In: Healthcare, vol. 10, p. 2366. MDPI","DOI":"10.3390\/healthcare10122366"},{"issue":"6","key":"3230_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/acps.12913","volume":"138","author":"A Tanskanen","year":"2018","unstructured":"Tanskanen A, Tiihonen J, Taipale H (2018) Mortality in schizophrenia: 30-year nationwide follow-up study. Acta Psychiatr Scand 138(6):492\u2013499","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"3230_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","volume":"8","author":"M De Hert","year":"2009","unstructured":"De Hert M, Schreurs V, Vancampfort D, Van Winkel R (2009) Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 8(1):15","journal-title":"World Psychiatry"},{"issue":"2","key":"3230_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1192\/apt.bp.113.011619","volume":"20","author":"CS Ho","year":"2014","unstructured":"Ho CS, Zhang MW, Mak A, Ho RC (2014) Metabolic syndrome in psychiatry: advances in understanding and management. Adv Psychiatr Treat 20(2):101\u2013112","journal-title":"Adv Psychiatr Treat"},{"issue":"10452","key":"3230_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, Ames D, Banerjee S, Burns A, Brayne C et al (2024) Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. The lancet 404(10452):572\u2013628","journal-title":"The lancet"},{"issue":"1","key":"3230_CR17","doi-asserted-by":"publisher","first-page":"18508","DOI":"10.1038\/s41598-025-93256-2","volume":"15","author":"C Wu","year":"2025","unstructured":"Wu C, Dagg P, Molgat C, Grishin N (2025) Smoking prevalence and correlates among inpatients with schizophrenia or schizoaffective disorder. Sci Rep 15(1):18508","journal-title":"Sci Rep"},{"issue":"3","key":"3230_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/YCO.0000000000000861","volume":"36","author":"DH Adamowicz","year":"2023","unstructured":"Adamowicz DH, Lee EE (2023) Dementia among older people with schizophrenia: an update on recent studies. Curr Opin Psychiatry 36(3):150\u2013155","journal-title":"Curr Opin Psychiatry"},{"key":"3230_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2021.111270","volume":"310","author":"WH Lee","year":"2021","unstructured":"Lee WH, Antoniades M, Schnack HG, Kahn RS, Frangou S (2021) Brain age prediction in schizophrenia: Does the choice of machine learning algorithm matter? Psychiatry Research Neuroimaging 310:111270","journal-title":"Psychiatry Research Neuroimaging"},{"issue":"1","key":"3230_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/schbul\/sbaa078","volume":"47","author":"P Kochunov","year":"2021","unstructured":"Kochunov P, Zavaliangos-Petropulu A, Jahanshad N, Thompson PM, Ryan MC, Chiappelli J, Chen S, Du X, Hatch K, Adhikari B et al (2021) A white matter connection of schizophrenia and alzheimer\u2019s disease. Schizophr Bull 47(1):197\u2013206","journal-title":"Schizophr Bull"},{"issue":"1","key":"3230_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41386-022-01426-x","volume":"48","author":"OD Howes","year":"2023","unstructured":"Howes OD, Cummings C, Chapman GE, Shatalina E (2023) Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes. Neuropsychopharmacology 48(1):151\u2013167","journal-title":"Neuropsychopharmacology"},{"key":"3230_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pnpbp.2013.04.019","volume":"45","author":"L Yao","year":"2013","unstructured":"Yao L, Lui S, Liao Y, Du M-Y, Hu N, Thomas JA, Gong Q-Y (2013) White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 45:100\u2013106","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"3230_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/npp.2013.288","volume":"39","author":"PR Szeszko","year":"2014","unstructured":"Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, Malhotra AK (2014) White matter changes associated with antipsychotic treatment in first-episode psychosis. Neuropsychopharmacology 39(6):1324\u20131331","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"3230_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1503\/jpn.230081","volume":"48","author":"S Sun","year":"2023","unstructured":"Sun S, Xiao S, Guo Z, Gong J, Tang G, Huang L, Wang Y (2023) Meta-analysis of cortical thickness reduction in adult schizophrenia. J Psychiatry Neurosci 48(6):461\u2013470","journal-title":"J Psychiatry Neurosci"},{"issue":"7","key":"3230_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamapsychiatry.2020.0036","volume":"77","author":"AN Voineskos","year":"2020","unstructured":"Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, Meyers BS, Alexopoulos GS, Hoptman MJ, Lerch JP et al (2020) Effects of antipsychotic medication on brain structure in patients with major depressive disorder and psychotic features: neuroimaging findings in the context of a randomized placebo-controlled clinical trial. JAMA Psychiat 77(7):674\u2013683","journal-title":"JAMA Psychiat"},{"issue":"6","key":"3230_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150(6):1115\u20131121","journal-title":"Am Heart J"},{"issue":"6","key":"3230_CR27","doi-asserted-by":"publisher","first-page":"67133","DOI":"10.1371\/journal.pone.0067133","volume":"8","author":"TM Laursen","year":"2013","unstructured":"Laursen TM, Wahlbeck K, H\u00e4llgren J, Westman J, \u00d6sby U, Alinaghizadeh H, Gissler M, Nordentoft M (2013) Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the nordic countries. PLoS ONE 8(6):67133","journal-title":"PLoS ONE"},{"key":"3230_CR28","first-page":"137","volume":"5","author":"PA Ringen","year":"2014","unstructured":"Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA (2014) Increased mortality in schizophrenia due to cardiovascular disease-a non-systematic review of epidemiology, possible causes, and interventions. Front Psych 5:137","journal-title":"Front Psych"},{"issue":"6","key":"3230_CR29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","volume":"44","author":"FJ Charlson","year":"2018","unstructured":"Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, McGrath JJ, Whiteford HA (2018) Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull 44(6):1195\u20131203","journal-title":"Schizophr Bull"},{"issue":"3","key":"3230_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-3223(97)00031-0","volume":"43","author":"GM Murphy Jr","year":"1998","unstructured":"Murphy GM Jr, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL, Nordahl T (1998) No neuropathologic evidence for an increased frequency of alzheimer\u2019s disease among elderly schizophrenics. Biol Psychiat 43(3):205\u2013209","journal-title":"Biol Psychiat"},{"issue":"3","key":"3230_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","volume":"55","author":"DP Purohit","year":"1998","unstructured":"Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL (1998) Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry 55(3):205\u2013211","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"3230_CR32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1176\/appi.ajp.160.5.867","volume":"160","author":"D Religa","year":"2003","unstructured":"Religa D, Laudon H, Styczynska M, Winblad B, N\u00e4slund J, Haroutunian V (2003) Amyloid $$\\beta $$ pathology in alzheimer\u2019s disease and schizophrenia. Am J Psychiatry 160(5):867\u2013872","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3230_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s004010050969","volume":"97","author":"K Jellinger","year":"1999","unstructured":"Jellinger K, Gabriel E (1999) No increased incidence of alzheimer\u2019s disease in elderly schizophrenics. Acta Neuropathol 97(2):165\u2013169","journal-title":"Acta Neuropathol"},{"key":"3230_CR34","first-page":"9","volume":"6","author":"KA Jellinger","year":"2025","unstructured":"Jellinger KA (2025) Morphological substrate of chronic schizophrenia in elderly patients: a clinicopathological study. Free Neuropathology 6:9","journal-title":"Free Neuropathology"},{"issue":"11","key":"3230_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1176\/ajp.155.11.1536","volume":"155","author":"AJ Dwork","year":"1998","unstructured":"Dwork AJ, Susser ES, Keilp J, Waniek C, Liu D, Kaufman M, Zemishlany Z, Prohovnik I (1998) Senile degeneration and cognitive impairment in chronic schizophrenia. Am J Psychiatry 155(11):1536\u20131543","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3230_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3940(02)00189-1","volume":"324","author":"VP Bozikas","year":"2002","unstructured":"Bozikas VP, K\u00f6vari E, Bouras C, Karavatos A (2002) Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci Lett 324(2):109\u2013112","journal-title":"Neurosci Lett"},{"issue":"1","key":"3230_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/pcn.13597","volume":"78","author":"S Arafuka","year":"2024","unstructured":"Arafuka S, Fujishiro H, Torii Y, Sekiguchi H, Habuchi C, Miwa A, Yoshida M, Iritani S, Iwasaki Y, Ikeda M et al (2024) Neuropathological substrate of incident dementia in older patients with schizophrenia: A clinicopathological study. Psychiatry Clin Neurosci 78(1):29\u201340","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"3230_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/brainsci14010041","volume":"14","author":"DF Weaver","year":"2023","unstructured":"Weaver DF (2023) Thirty risk factors for alzheimer\u2019s disease unified by a common neuroimmune-neuroinflammation mechanism. Brain Sci 14(1):41","journal-title":"Brain Sci"},{"issue":"1","key":"3230_CR39","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/s41467-024-46344-2","volume":"15","author":"J Manuello","year":"2024","unstructured":"Manuello J, Min J, McCarthy P, Alfaro-Almagro F, Lee S, Smith S, Elliott LT, Winkler AM, Douaud G (2024) The effects of genetic and modifiable risk factors on brain regions vulnerable to ageing and disease. Nat Commun 15(1):2576","journal-title":"Nat Commun"},{"key":"3230_CR40","doi-asserted-by":"publisher","first-page":"1257460","DOI":"10.3389\/fpsyt.2023.1257460","volume":"14","author":"KR Mortimer","year":"2023","unstructured":"Mortimer KR, Katshu MZUH, Chakrabarti L (2023) Second-generation antipsychotics and metabolic syndrome: a role for mitochondria. Front Psych 14:1257460","journal-title":"Front Psych"},{"issue":"1","key":"3230_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40001-022-00706-y","volume":"27","author":"N Yong","year":"2022","unstructured":"Yong N, Pan J, Li X, Yu L, Hou X (2022) Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study. Eur J Med Res 27(1):90","journal-title":"Eur J Med Res"},{"issue":"18","key":"3230_CR42","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.3390\/ijerph17186700","volume":"17","author":"MJ Sun","year":"2020","unstructured":"Sun MJ, Jang MH (2020) Risk factors of metabolic syndrome in community-dwelling people with schizophrenia. Int J Environ Res Public Health 17(18):6700","journal-title":"Int J Environ Res Public Health"},{"key":"3230_CR43","doi-asserted-by":"crossref","unstructured":"Rodriguez FS, Hofbauer LM, Reppermund S, Samtani S, R\u00f6hr S (2025) Updating risk and protective factors for dementia in older adults. Nature Reviews Psychology 1\u201314","DOI":"10.1038\/s44159-025-00438-w"},{"issue":"21","key":"3230_CR44","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1073\/pnas.1502170112","volume":"112","author":"MM Nour","year":"2015","unstructured":"Nour MM, Howes OD (2015) Interpreting the neurodevelopmental hypothesis of schizophrenia in the context of normal brain development and ageing. Proc Natl Acad Sci 112(21):2745\u20132745","journal-title":"Proc Natl Acad Sci"},{"issue":"49","key":"3230_CR45","doi-asserted-by":"publisher","first-page":"17648","DOI":"10.1073\/pnas.1410378111","volume":"111","author":"G Douaud","year":"2014","unstructured":"Douaud G, Groves AR, Tamnes CK, Westlye LT, Duff EP, Engvig A, Walhovd KB, James A, Gass A, Monsch AU et al (2014) A common brain network links development, aging, and vulnerability to disease. Proc Natl Acad Sci 111(49):17648\u201317653","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3230_CR46","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41380-022-01897-w","volume":"28","author":"C Constantinides","year":"2023","unstructured":"Constantinides C, Han LK, Alloza C, Antonucci LA, Arango C, Ayesa-Arriola R, Banaj N, Bertolino A, Borgwardt S, Bruggemann J et al (2023) Brain ageing in schizophrenia: evidence from 26 international cohorts via the enigma schizophrenia consortium. Mol Psychiatry 28(3):1201\u20131209","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3230_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0006-3223(97)00013-9","volume":"43","author":"JS Krasuski","year":"1998","unstructured":"Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro MB (1998) Volumes of medial temporal lobe structures in patients with alzheimer\u2019s disease and mild cognitive impairment (and in healthy controls). Biol Psychiat 43(1):60\u201368","journal-title":"Biol Psychiat"},{"issue":"4","key":"3230_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/mp.2015.63","volume":"21","author":"TG Erp","year":"2016","unstructured":"Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM et al (2016) Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the enigma consortium. Mol Psychiatry 21(4):547\u2013553","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3230_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41398-024-02822-1","volume":"14","author":"A Baranova","year":"2024","unstructured":"Baranova A, Zhao Q, Cao H, Chandhoke V, Zhang F (2024) Causal influences of neuropsychiatric disorders on alzheimer\u2019s disease. Transl Psychiatry 14(1):114","journal-title":"Transl Psychiatry"},{"issue":"2","key":"3230_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/braincomms\/fcaf112","volume":"7","author":"I Sousa","year":"2025","unstructured":"Sousa I, Grotzinger AD, Lawrence JM, Breunig S, Marshall CR, Korszun A, Foote IF (2025) Examining the genetic relationship between alzheimer\u2019s disease, schizophrenia and their shared risk factors using genomic structural equation modelling. Brain Communications 7(2):112","journal-title":"Brain Communications"},{"issue":"8","key":"3230_CR51","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1017\/S003329171000156X","volume":"41","author":"V Cheung","year":"2011","unstructured":"Cheung V, Chiu C, Law C, Cheung C, Hui C, Chan K, Sham P, Deng M, Tai K, Khong P-L et al (2011) Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychol Med 41(8):1709\u20131719","journal-title":"Psychol Med"},{"issue":"1","key":"3230_CR52","doi-asserted-by":"publisher","first-page":"12994","DOI":"10.1038\/srep12994","volume":"5","author":"W Lei","year":"2015","unstructured":"Lei W, Li N, Deng W, Li M, Huang C, Ma X, Wang Q, Guo W, Li Y, Jiang L et al (2015) White matter alterations in first episode treatment-na\u00efve patients with deficit schizophrenia: a combined vbm and dti study. Sci Rep 5(1):12994","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"3230_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2016.01.051","volume":"172","author":"B Zeng","year":"2016","unstructured":"Zeng B, Ardekani BA, Tang Y, Zhang T, Zhao S, Cui H, Fan X, Zhuo K, Li C, Xu Y et al (2016) Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment. Schizophr Res 172(1\u20133):1\u20138","journal-title":"Schizophr Res"},{"issue":"3","key":"3230_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsgos.2025.100472","volume":"5","author":"PC Van Dyken","year":"2025","unstructured":"Van Dyken PC, Yang K, Faria AV, Sawa A, MacKinley M, Khan AR, Palaniyappan L (2025) Stable white matter structure in the first three years after psychosis onset. Biological Psychiatry Global Open Science 5(3):100472","journal-title":"Biological Psychiatry Global Open Science"},{"issue":"1","key":"3230_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.9758\/cpn.2012.10.1.13","volume":"10","author":"CN Kuswanto","year":"2012","unstructured":"Kuswanto CN, Teh I, Lee T-S, Sim K (2012) Diffusion tensor imaging findings of white matter changes in first episode schizophrenia: a systematic review. Clinical Psychopharmacology and Neuroscience 10(1):13","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"4","key":"3230_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0963721410377601","volume":"19","author":"KH Karlsgodt","year":"2010","unstructured":"Karlsgodt KH, Sun D, Cannon TD (2010) Structural and functional brain abnormalities in schizophrenia. Curr Dir Psychol Sci 19(4):226\u2013231","journal-title":"Curr Dir Psychol Sci"},{"issue":"2","key":"3230_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00001504-200503000-00004","volume":"18","author":"M Kubicki","year":"2005","unstructured":"Kubicki M, McCarley RW, Shenton ME (2005) Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry 18(2):121\u2013134","journal-title":"Curr Opin Psychiatry"},{"issue":"11","key":"3230_CR58","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1017\/S003329172200174X","volume":"53","author":"L Townsend","year":"2023","unstructured":"Townsend L, Pillinger T, Selvaggi P, Veronese M, Turkheimer F, Howes O (2023) Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18fdg-pet studies in schizophrenia. Psychol Med 53(11):4880\u20134897","journal-title":"Psychol Med"},{"issue":"8","key":"3230_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/archgenpsychiatry.2009.91","volume":"66","author":"MJ Minzenberg","year":"2009","unstructured":"Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC (2009) Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 66(8):811\u2013822","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"3230_CR60","first-page":"8","volume":"64","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW (2007) Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 64(4):8\u201313","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"3230_CR61","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1038\/s41591-025-03891-5","volume":"31","author":"Y Liu","year":"2025","unstructured":"Liu Y, Gu X, Li Y, Wang F, Vyas CM, Peng C, Dong D, Li Y, Zhang Y, Zhang Y et al (2025) Interplay of genetic predisposition, plasma metabolome and mediterranean diet in dementia risk and cognitive function. Nat Med 31(11):3790\u20133800","journal-title":"Nat Med"},{"issue":"5","key":"3230_CR62","doi-asserted-by":"publisher","first-page":"7228","DOI":"10.18632\/aging.202580","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang J, Cui C, Su Y, Jing D, Wu L, Liang P, Liang Z (2021) Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in alzheimer\u2019s disease: A pet\/mri study. Aging (Albany NY) 13(5):7228","journal-title":"Aging (Albany NY)"},{"key":"3230_CR63","first-page":"46","volume":"2","author":"F Nobili","year":"2010","unstructured":"Nobili F, Morbelli S (2010) Fdg-pet as a biomarker for early alzheimer\u2019s disease. The Open Nuclear Medicine Journal 2:46\u201352","journal-title":"The Open Nuclear Medicine Journal"},{"issue":"46","key":"3230_CR64","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1523\/JNEUROSCI.1402-13.2013","volume":"33","author":"LL Beason-Held","year":"2013","unstructured":"Beason-Held LL, Goh JO, An Y, Kraut MA, O\u2019Brien RJ, Ferrucci L, Resnick SM (2013) Changes in brain function occur years before the onset of cognitive impairment. J Neurosci 33(46):18008\u201318014","journal-title":"J Neurosci"},{"key":"3230_CR65","doi-asserted-by":"crossref","unstructured":"Vahid A, Zamani J, Hadi\u00a0Hosseini S (2025) Predicting future amyloid conversion: the role of baseline amyloid distribution, genetic and cognitive resilience. npj Dementia 1(1), 40","DOI":"10.1038\/s44400-025-00041-z"},{"issue":"2","key":"3230_CR66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000516164","volume":"11","author":"SA Hasani","year":"2021","unstructured":"Hasani SA, Mayeli M, Salehi MA, Barzegar Parizi R (2021) A systematic review of the association between amyloid-$$\\beta $$ and $$\\tau $$ pathology with functional connectivity alterations in the alzheimer dementia spectrum utilizing pet scan and rsfmri. Dementia and Geriatric Cognitive Disorders Extra 11(2):78\u201390","journal-title":"Dementia and Geriatric Cognitive Disorders Extra"},{"key":"3230_CR67","doi-asserted-by":"crossref","unstructured":"Wilson JC, Liu KY, Jones K, Mahmood J, Arya U, Howard R (2024) Biomarkers of neurodegeneration in schizophrenia: systematic review and meta-analysis. BMJ Mental Health 27(1):","DOI":"10.1136\/bmjment-2024-301017"},{"issue":"Supplement 1","key":"3230_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD (2022) The role of amyloid pet in imaging neurodegenerative disorders: a review. J Nucl Med 63(Supplement 1):13\u201319","journal-title":"J Nucl Med"},{"issue":"5","key":"3230_CR69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archpsyc.55.5.433","volume":"55","author":"MD Nelson","year":"1998","unstructured":"Nelson MD, Saykin AJ, Flashman LA, Riordan HJ (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55(5):433\u2013440","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"3230_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1192\/bjp.bp.113.140384","volume":"205","author":"N Pujol","year":"2014","unstructured":"Pujol N, Penad\u00e9s R, Junqu\u00e9 C, Dinov I, Fu CH, Catal\u00e1n R, Ibarretxe-Bilbao N, Bargall\u00f3 N, Bernardo M, Toga A et al (2014) Hippocampal abnormalities and age in chronic schizophrenia: morphometric study across the adult lifespan. Br J Psychiatry 205(5):369\u2013375","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3230_CR71","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1212\/WNL.49.3.786","volume":"49","author":"CR Jack Jr","year":"1997","unstructured":"Jack CR Jr, Petersen RC, Xu YC, Waring SC, O\u2019Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on mri in normal aging and very mild alzheimer\u2019s disease. Neurology 49(3):786\u2013794","journal-title":"Neurology"},{"key":"3230_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fneur.2012.00063","volume":"3","author":"L Alves","year":"2012","unstructured":"Alves L, Correia ASA, Miguel R, Alegria P, Bugalho P (2012) Alzheimer\u2019s disease: a clinical practice-oriented review. Front Neurol 3:63","journal-title":"Front Neurol"},{"issue":"1","key":"3230_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/joa.70027","volume":"248","author":"E Bruner","year":"2026","unstructured":"Bruner E, Gallareto-Sande R, L\u00f3pez-Gonz\u00e1lez FJ, Zhang L, S\u00e1nchez Mart\u00edn C, Grothe MJ, S\u00e1nchez-Juan P (2026) Morphological variations and cortical atrophy of the precuneus in normal aging and alzheimer\u2019s disease. J Anat 248(1):62\u201370","journal-title":"J Anat"},{"key":"3230_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/alz.13466","volume":"19","author":"A Touroutoglou","year":"2023","unstructured":"Touroutoglou A, Katsumi Y, Brickhouse M, Zaitsev A, Eckbo R, Aisen P, Beckett L, Dage JL, Eloyan A, Foroud T et al (2023) The sporadic early-onset alzheimer\u2019s disease signature of atrophy: preliminary findings from the longitudinal early-onset alzheimer\u2019s disease study (leads) cohort. Alzheimer\u2019s & Dementia 19:74\u201388","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"7","key":"3230_CR75","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00406-011-0202-x","volume":"261","author":"G Horga","year":"2011","unstructured":"Horga G, Bernacer J, Dusi N, Entis J, Chu K, Hazlett EA, Mehmet Haznedar M, Kemether E, Byne W, Buchsbaum MS (2011) Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur Arch Psychiatry Clin Neurosci 261(7):467\u2013476","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"9","key":"3230_CR76","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/brain\/awn146","volume":"131","author":"SM Nestor","year":"2008","unstructured":"Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R, Initiative ADN (2008) Ventricular enlargement as a possible measure of alzheimer\u2019s disease progression validated using the alzheimer\u2019s disease neuroimaging initiative database. Brain 131(9):2443\u20132454","journal-title":"Brain"},{"issue":"4","key":"3230_CR77","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/brain\/aww008","volume":"139","author":"M Habes","year":"2016","unstructured":"Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, Rosseel Y, Janowitz D, Doshi J, Auwera S et al (2016) White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 139(4):1164\u20131179","journal-title":"Brain"},{"key":"3230_CR78","doi-asserted-by":"crossref","unstructured":"Staffaroni AM, Elahi FM, McDermott D, Marton K, Karageorgiou E, Sacco S, Paoletti M, Caverzasi E, Hess CP, Rosen HJ, et al (2017) Neuroimaging in dementia. In: Seminars in Neurology, vol. 37, pp. 510\u2013537. Thieme Medical Publishers","DOI":"10.1055\/s-0037-1608808"},{"key":"3230_CR79","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fnins.2016.00582","volume":"10","author":"J Mutlu","year":"2016","unstructured":"Mutlu J, Landeau B, Tomadesso C, De Flores R, M\u00e9zenge F, La Sayette V, Eustache F, Ch\u00e9telat G (2016) Connectivity disruption, atrophy, and hypometabolism within posterior cingulate networks in alzheimer\u2019s disease. Front Neurosci 10:582","journal-title":"Front Neurosci"},{"issue":"10","key":"3230_CR80","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jagp.2016.03.013","volume":"24","author":"JK Chung","year":"2016","unstructured":"Chung JK, Nakajima S, Plitman E, Iwata Y, Uy D, Gerretsen P, Caravaggio F, Chakravarty MM, Graff-Guerrero A (2016) B-amyloid burden is not associated with cognitive impairment in schizophrenia: a systematic review. Am J Geriatr Psychiatry 24(10):923\u2013939","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"3230_CR81","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","volume":"126","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Barrio JR, Kepe V (2013) Cerebral amyloid pet imaging in alzheimer\u2019s disease. Acta Neuropathol 126(5):643\u2013657","journal-title":"Acta Neuropathol"},{"key":"3230_CR82","doi-asserted-by":"publisher","first-page":"81869","DOI":"10.7554\/eLife.81869","volume":"12","author":"PR Millar","year":"2023","unstructured":"Millar PR, Gordon BA, Luckett PH, Benzinger TL, Cruchaga C, Fagan AM, Hassenstab JJ, Perrin RJ, Schindler SE, Allegri RF et al (2023) Multimodal brain age estimates relate to alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife 12:81869","journal-title":"Elife"},{"key":"3230_CR83","doi-asserted-by":"crossref","unstructured":"Longkumer I, Patil R (2024) Cognitive dysfunction and its relationship with psychopathology and quality of life in patients with schizophrenia: a protocol for a cross sectional study. F1000Research 13, 442","DOI":"10.12688\/f1000research.143365.1"},{"issue":"1","key":"3230_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.2009.199505","volume":"82","author":"BC Dickerson","year":"2011","unstructured":"Dickerson BC, Wolk DA, Initiative ADN et al (2011) Dysexecutive versus amnesic phenotypes of very mild alzheimer\u2019s disease are associated with distinct clinical, genetic and cortical thinning characteristics. Journal of Neurology Neurosurgery & Psychiatry 82(1):45\u201351","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03230-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:02:13Z","timestamp":1788537733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03230-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3230"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03230-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no conflict of interest exist.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}